Praxis Precision Medicines. has filed a patent for deuterium-enriched compounds targeting T-type calcium channel-related diseases. Claim 1 specifies a compound formula. GlobalData’s report on Praxis Precision Medicines gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Praxis Precision Medicines, Peptide pharmacophores was a key innovation area identified from patents. Praxis Precision Medicines's grant share as of January 2024 was 13%. Grant share is based on the ratio of number of grants to total number of patents.
The patent application (Publication Number: US20240025852A1) discloses a compound of Formula (I) and its various derivatives, including pharmaceutically acceptable salts. The compounds described in the claims have specific configurations and substitutions, such as deuterium atoms at certain positions, which are intended to enhance their therapeutic properties.
Furthermore, the patent application covers pharmaceutical compositions containing the disclosed compounds along with suitable excipients. Additionally, the application outlines methods for treating various neurological and psychiatric disorders, pain, tremors, seizures, epilepsy, and epilepsy syndromes by administering the compound of claim 1 or its salts to individuals in need of such treatment. Specific disorders mentioned include mood disorders, major depressive disorder, essential tremor, absence seizures, and juvenile myoclonic epilepsy. The compounds and methods described in the patent aim to provide effective therapeutic options for a range of medical conditions, highlighting the potential impact of this innovation in the field of pharmaceuticals.
To know more about GlobalData’s detailed insights on Praxis Precision Medicines, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
